| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |